Radial Extracorporeal Shock Wave Therapy for Triceps Surae Spasticity in People With Multiple Sclerosis: A Pilot Study.

BACKGROUND: Spasticity represents a major symptom of people with multiple sclerosis (MS), frequently causing disability, pain, and abnormal postures. The aim of this study is the evaluation of safety and efficacy of radial extracorporeal shock wave therapy (RESWT) for triceps surae muscle spastic hy...

Descripción completa

Detalles Bibliográficos
Publicado en:International Journal of MS Care Vol. 28; no. 3; pp. 146 - 151
Autores principales: Di Giovanni, Rachele, Grange, Erica, Masuccio, Fabio Giuseppe, Bodrero, Matteo, Puce, Luca, Trompetto, Carlo, Solaro, Claudio Marcello
Formato: pictorial research tables/charts Journal Article
Publicado: Consortium of Multiple Sclerosis Centers May/Jun2026
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=196172525&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 196172525
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        15372073
        1FUA
      jtl: International Journal of MS Care
      issn: 15372073
      maglogo: N
    pubinfo:
      dt: May/Jun2026
      vid: 28
      iid: 3
      pid: 66082
      pub: Consortium of Multiple Sclerosis Centers
      place: Hackensack, New Jersey
    artinfo:
      ui:
        196172525
        196172525
        196172525
        10.7224/1537-2073.2024-089
        196172525
      ppf: 146
      ppct: 5
      formats:
      tig:
        atl: Radial Extracorporeal Shock Wave Therapy for Triceps Surae Spasticity in People With Multiple Sclerosis: A Pilot Study.
      aug:
        au:
          Di Giovanni, Rachele
          Grange, Erica
          Masuccio, Fabio Giuseppe
          Bodrero, Matteo
          Puce, Luca
          Trompetto, Carlo
          Solaro, Claudio Marcello
        affil: Department of Rehabilitation, C.R.R.F. "Mons. Luigi Novarese," Moncrivello, Italy
      sug:
        subj:
          Multiple Sclerosis Pathology
          Muscle Spasticity Therapy
          Triceps Surae Muscles Physiology
          Ultrasonic Therapy Methods
          Balance, Postural
          Functional Assessment
          Treatment Outcomes
          Human
          Male
          Female
          Pilot Studies
          Multicenter Studies
          Comparative Studies
          Descriptive Statistics
          Kruskal-Wallis Test
          Chi Square Test
          Spearman's Rank Correlation Coefficient
          Nonparametric Statistics
          Wilcoxon Signed Rank Test
          Clinical Assessment Tools
          Male
          Female
      ab: BACKGROUND: Spasticity represents a major symptom of people with multiple sclerosis (MS), frequently causing disability, pain, and abnormal postures. The aim of this study is the evaluation of safety and efficacy of radial extracorporeal shock wave therapy (RESWT) for triceps surae muscle spastic hypertonia in people with MS. METHODS: Two centers recruited people 18 years or older with MS and triceps surae muscle hypertonia. People were excluded if they had other neurological conditions; had used anticoagulants; had intrathecal baclofen, botulinum toxin, and/or physiotherapy within the past 8 months; or had oral antispasmodics therapy modification in the past 4 weeks. The participants underwent triceps surae RESWT once a week for 4 weeks. Participants were scored on the Modified Ash-worth Scale (MAS), the Numerical Rating Scale for spasticity (NRS-Sp), the Medical Research Council (MRC) scale, the Timed Up and Go (TUG) test, and the Timed 25-Foot Walk (T25-FW) test before RESWT (To) and immediately after RESWT (Ti). Self-perceived effect was evaluated via the Global Perceived Effect (GPE) at Ti. RESULTS: Twenty-six people with MS were included (10 women and 16 men; mean age ± SD, 52.46 ± 8.39 years; mean Expanded Disability Status Scale score ± SD, 5.44 ± 1.34; mean disease duration ± SD, 14.88 ± 10.83 years), and 36 triceps surae were treated. MAS and NRS-Sp scores decreased at T1, whereas TUG, T25-FW, and MRC scores were comparable over time. Via the GPE, 73% of participants reported a self-perceived positive effect of RESWT on spasticity. CONCLUSIONS: RESWT may be efficacious and safe for treating spasticity in people with MS and does not adversely affect gait, strength, or dynamic balance. Further long-term studies are needed to evaluate the possibility of using RESWT as a treatment for spasticity in people with MS.
      pubtype: Academic Journal
      doctype:
        pictorial
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N